First human test for new peanut allergy drug begins
Disease control
Completed
This was an early safety study to test a new drug called IGNX001 for peanut allergy. It involved 32 adults and older teenagers with confirmed peanut allergies. The main goal was to see if single, gradually increasing doses were safe and how the drug behaved in the body, not to tr…
Phase: PHASE1 • Sponsor: IgGenix Australia Pty Ltd • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC